Predictive Biomarkers
Source: ACR Image Metrix
Pharmaceutical Contract research- The use of imaging as a predictive biomarker is proving to be successful in all stages of drug development. ACR Image Metrix provides you with access to the most experienced network of imaging researchers. We have more than 180 research sites in the American College of Radiology Imaging Network (ACRIN), upon which ACR Image Metrix is based.
Click Here To Download:
Company Brochure: American College Of Radiology (ACR) Image Metrix
Company Brochure: American College Of Radiology (ACR) Image Metrix
Company Brochure: American College Of Radiology (ACR) Image Metrix
Pharmaceutical Contract research- The use of imaging as a predictive biomarker is proving to be successful in all stages of drug development.
ACR Image Metrix provides you with access to the most experienced network of imaging researchers. We have more than 180 research sites in the American College of Radiology Imaging Network (ACRIN), upon which ACR Image Metrix is based. Our team of physicians and scientists partner with you to identify the appropriate imaging modality that best addresses the development demands of their specific therapeutic category and drug.
This usage of imaging as a predictive or prognostic biomarker has numerous applications, including:
- Phase I/II trials for early assessment of efficacy
- Phase II trials in conjunction with conventional anatomical measures
- Correlative trials with histopathological and genomic data
- Adaptive trials to assign subjects to treatment arms
Company Brochure: American College Of Radiology (ACR) Image Metrix
This website uses cookies to ensure you get the best experience on our website. Learn more